Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05047094 |
| Title | A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC |
| Recruitment | Recruiting |
| Gender | both |
| Phase | |
| Variant Requirements | No |
| Sponsors | Alpha Tau Medical LTD. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | ISR |